{"id":651,"date":"2018-10-02T00:00:00","date_gmt":"2018-10-01T15:00:00","guid":{"rendered":"https:\/\/wwwt.kanazawa-med.ac.jp\/~ophthal\/?page_id=651"},"modified":"2018-10-02T00:00:00","modified_gmt":"2018-10-01T15:00:00","slug":"2016%e5%b9%b4%e5%ba%a6","status":"publish","type":"page","link":"https:\/\/ganka-kanazawamed.jp\/?page_id=651","title":{"rendered":"2020\u5e74\u5ea6"},"content":{"rendered":"\n

2020\u5e74\u5ea6<\/h2>\n\n\n\n

\u82f1\u6587\u539f\u8457<\/h4>\n\n\n
\n
    \n
  1. Hidetoshi Ishida, Teppei Shibata, Yuka Nakamura, Yasuhito Ishigaki, Dhirendra P. Singh, Hiroshi Sasaki, Eri Kubo.
    Identification of Differential Gene Expression Pattern in Lens Epithelial Cells Derived from Cataractous and Noncataractous Lenses of Shumiya Cataract Rat.
    BioMed Research International. 2020: 7319590.
    <\/strong><\/li>\n
  2. Yosuke Nakazawa, Teppei Shibata, Noriaki Nagai, Eri Kubo, Hiroomi Tamura, Hiroshi Sasaki.
    Degradation of connexin 50 protein causes waterclefts in human lens.
    Open Medicine. 2020:15(1), 1163-1171.
    <\/strong><\/li>\n
  3. Tsuyoshi Mito, Takeshi Kobayashi, Atsushi Shiraishi.
    Central scotoma after indocyanine green assisted fovea-sparing internal limiting membrane peeling.
    American Journal of Ophthalmology Case Reports. 2020:20: 100942.
    <\/strong><\/li>\n
  4. Naoki Yamamoto, Shun Takeda, Natsuko Hatsusaka, Noriko Hiramatsu, Noriaki Nagai, Saori Deguchi, Yosuke Nakazawa, Takumi Takata, Sachiko Kodera, Akimasa Hirata, Eri Kubo, Hiroshi Sasaki.
    Effect of a Lens Protein in Low-Temperature Culture of Novel Immortalized Human Lens Epithelial Cells (iHLEC-NY2).
    Cells. 2020:9(12): 2670.
    <\/strong><\/li>\n
  5. Yoshinao Kato, Naoki Yamamoto, Noriko Hiramatsu, Atushi Sato, Hajime Kojima.
    Inhouse Fabrication of a Reconstructed Human Corneal Epithelium Model for Use in Testing for Eye Irritation Potential.
    Applied in vitro Toxicology. 2020:6(3), 99-106.
    <\/strong><\/li>\n
  6. Norihiro Mita, Hiroshi Sasaki, Tomofusa Yamauchi, Kazutaka Kani, Akio Tabuchi, Heihachiro Hara.
    The Visual Acuity Measurement and its Multiple Testing for Patients Implanted with Intraocular Lenses During the Cataract Surgery.\u00a0
    Italian Journal of Applied Statistics. 2020:32(3), 269-284.
    <\/strong><\/li>\n
  7. Chhunchha B, Kubo E, Singh DP.
    ClockProtein Bmal1 and Nrf2 Cooperatively Control Aging or Oxidative Response andRedox Homeostasis by Regulating Rhythmic Expression of Prdx6.
    Cells 2020; 9(8): 1861.
    <\/strong><\/li>\n
  8. Hiramatsu N, Yamamoto N, Isogai S, OnouchiT, Hirayama M, Maeda S, Ina T, Kondo M, Imaizumi K.
    An analysis of monocytesand dendritic cells differentiated from human peripheral blood monocyte-derivedinduced pluripotent stem cells.
    Med Mol Morphol 2020; 53(2): 63-72.
    <\/strong><\/li>\n
  9. Ishida H, Shibata T, Shibata S, Tanaka Y,Sasaki H, Kubo E.
    Lutein plus Water Chestnut (Trapa bispinosa Roxb.) ExtractInhibits the Development of Cataracts and Induces Antioxidant Gene Expressionin Lens Epithelial Cells.
    Biomed Res Int 2020; 2020(12): 9204620.
    <\/strong><\/li>\n
  10. Kojima M, Suzuki Y, Tasaki T, Tatematsu Y,Mizuno M, Fukunari M, Sasaki H.
    Clinical Course of High-FrequencyMillimeter-Wave (162 GHz) Induced Ocular Injuries and Investigation ofDamage Thresholds.
    Journal of Infrared, Millimeter, and Terahertz Waves 2020; 41(7): 834-845.
    <\/strong><\/li>\n
  11. Mano Y, Otake H, Shibata T, Kubo E, SasakiH, Nagai N.
    Enhancement of Amyloid \u03b21-43 Production in the Lens Epithelium ofJapanese Type 2 Diabetic Patients.
    Biomedicines 2020; 8(4): 87.
    <\/strong><\/li>\n
  12. Mita N, Sasaki H, Kani K, Tabuchi A, HaraH. A statistical modelling of the visual acuity measurement and its multipletest procedure.
    Electronic Journal of Applied Statistical Analysis 2020; 13(1): 1-15.
    <\/strong><\/li>\n
  13. Nagai N, Minami M, Deguchi S, Otake H,Sasaki H, Yamamoto N.
    An In Situ Gelling System based on Methylcellulose andTranilast Solid Nanoparticles Enhances Ocular Residence Time and DrugAbsorption into the Cornea and Conjunctiva.
    Front Bioeng Biotechnol 2020; 8: 764.
    <\/strong><\/li>\n
  14. Nagai N, Seiriki R, Deguchi S, Otake H,Hiramatsu N, Sasaki H, Yamamoto N.
    Hydrogel Formulations Incorporating DrugNanocrystals Enhance the Therapeutic Effect of Rebamipide in a Hamster Modelfor Oral Mucositis.
    Pharmaceutics 2020; 12(6): 532.
    <\/strong><\/li>\n
  15. Nagai N, Umachi K, Otake H, Oka M,Hiramatsu N, Sasaki H, Yamamoto N.
    Ophthalmic In Situ Gelling System ContainingLanosterol Nanoparticles Delays Collapse of Lens Structure in Shumiya CataractRats.
    Pharmaceutics 2020; 12(7): 629.
    <\/strong><\/li>\n
  16. Shibata N, Ishida H, Kiyokawa E, Singh DP,Sasaki H, Kubo E.
    Relative gene expression analysis of human pterygium tissuesand UV radiation-evoked gene expression patterns in corneal and conjunctival cells.
    Experimental Eye Research 2020; 199: 108194.
    <\/strong><\/li>\n
  17. Yamamoto N, Hiramatsu N, Isogai S, Kondo M,Imaizumi K, Horiguchi M.
    Mechanism of atopic cataract caused by eosinophilgranule major basic protein.
    Med Mol Morphol 2020; 53(2): 94-103.<\/strong><\/li>\n
  18. Kodera S, Hirata A, Miura F, Rashed EA, Hatsusaka N, Yamamoto N, Kubo E, Sasaki H.
    Model-based approach for analyzing prevalence of nuclear cataracts in elderly residents.
    Comput Biol Med. 2020 Nov;126:104009. <\/strong><\/li>\n<\/ol>\n<\/div>\n\n\n
    <\/div>\n\n\n\n

    \u90a6\u6587\u539f\u8457<\/h4>\n\n\n
      \n
    1. \u67f4\u7530\u54f2\u5e73. \u6c34\u6676\u4f53\u306e\u4e0a\u76ae\u9593\u8449\u7cfb\u79fb\u884c\u3068\u5206\u5316\u306b\u304a\u3051\u308b\u30c8\u30ed\u30dd\u30df\u30aa\u30b7\u30f3\u306e\u5f79\u5272. \u65e5\u672c\u767d\u5185\u969c\u5b66\u4f1a\u8a8c 2020: 32(1): 7-10. <\/strong>\n

      <\/p>\n<\/li>\n

    2. \u5c71\u672c\u76f4\u6a39, \u5e73\u677e\u7bc4\u5b50, \u4e45\u4fdd\u6c5f\u7406, \u4f50\u3005\u6728\u6d0b. \u7d30\u80de\u57fa\u5e95\u819c\u3068\u3057\u3066\u306e\u6c34\u6676\u4f53\u56ca\u306e\u5f79\u5272. \u65e5\u672c\u767d\u5185\u969c\u5b66\u4f1a\u8a8c 2020: 32(1): 41-43. <\/strong>\n

      <\/p>\n<\/li>\n

    3. \u77f3\u7530\u79c0\u4fca, \u4e09\u7530\u54f2\u5927, \u6e0b\u8c37\u6075\u7406, \u5c71\u5d0e\u821e, \u4f0a\u4e95\u5f69, \u9d5c\u98fc\u7950\u8f1d, \u9ad8\u5c71\u7dbe\u5b50, \u67f4\u7530\u5948\u592e\u5b50, \u4e45\u4fdd\u6c5f\u7406, \u4f50\u3005\u6728\u6d0b. 3\u7a2e\u985e\u306e\u5358\u7126\u70b9\u773c\u5185\u30ec\u30f3\u30ba\u306e\u767d\u5185\u969c\u8853\u5f8c\u306e\u524d\u623f\u6df1\u5ea6\u3068\u5c48\u6298\u5909\u5316\u306e\u6bd4\u8f03. \u65e5\u672c\u767d\u5185\u969c\u5b66\u4f1a\u8a8c 2020: 32(1): 58-62. <\/strong>\n

      <\/p>\n<\/li>\n

    4. \u4f50\u3005\u6728\u6d0b. \u767d\u5185\u969c\u6cbb\u7642\uff0d\u6700\u826f\u306e\u8853\u5f8c\u8996\u6a5f\u80fd\u3092\u76ee\u6307\u3057\u3066\uff0d. IOL&RS 2020: 34(2): 254-261. <\/strong>\n

      <\/p>\n<\/li>\n

    5. \u521d\u5742\u5948\u6d25\u5b50, \u4f50\u3005\u6728\u6d0b. \u7814\u7a76\u8005\u306e\u6700\u65b0\u52d5\u5411 \u30de\u30cd\u30ad\u30f3\u578b\u7d2b\u5916\u7dda\u30bb\u30f3\u30b5\u30fc\u3092\u7528\u3044\u305f\u773c\u90e8\u7d2b\u5916\u7dda\u88ab\u3070\u304f\u306e\u8a55\u4fa1. Precision Medicine 2020: 3(2): 161-165. <\/strong>\n

      <\/p>\n<\/li>\n

    6. \u798f\u7530\u6b63\u9053, \u4f50\u3005\u6728\u6d0b. \u89d2\u819c\u62b5\u6297\u6e2c\u5b9a\u6cd5\u306b\u3088\u308b\u30d2\u30a2\u30eb\u30ed\u30f3\u9178\u30ca\u30c8\u30ea\u30a6\u30e0\u70b9\u773c\u6db2\u4e2d\u306e\u5404\u7a2e\u6dfb\u52a0\u7269\u306e\u89d2\u819c\u4e0a\u76ae\u7d30\u80de\u306b\u5bfe\u3059\u308b\u5b89\u5168\u6027\u306e\u8a55\u4fa1. \u533b\u5b66\u3068\u85ac\u5b66 2020: 77(3): 379-383.
      \n<\/strong>

      <\/p>\n

      <\/strong><\/p>\n<\/li>\n

    7. \u8429\u539f\u5065\u592a, \u5317\u5ddd\u548c\u5b50, \u795e\u5c71\u5e78\u6d69, \u8c37\u6751\u76f4\u7d00, \u98ef\u6cbc\u7531\u55e3, \u4f50\u3005\u6728\u6d0b. \u30c7\u30a3\u30b9\u30af\u6cd5\u3067\u591a\u5264\u8010\u6027\u3092\u793a\u3057\u305f\u30b3\u30ea\u30cd\u30d0\u30af\u30c6\u30ea\u30a6\u30e0\u72b6\u30b0\u30e9\u30e0\u967d\u6027\u687f\u83cc\u304c\u5206\u96e2\u3055\u308c\u305f\u524d\u773c\u90e8\u611f\u67d3\u75c7\u306e5\u75c7\u4f8b\u306e\u691c\u8a0e. \u3042\u305f\u3089\u3057\u3044\u773c\u79d1 2020: 35(5): 619-623.<\/strong><\/li>\n<\/ol>\n

      <\/p>\n\n\n

      <\/div>\n\n\n\n

      \u90a6\u6587\u8457\u66f8<\/h4>\n\n\n
        \n
      1. \u4e45\u4fdd\u6c5f\u7406. I\u5dfb I. \u69cb\u9020\u3068\u305d\u306e\u5f62\u614b G. \u6c34\u6676\u4f53 1. \u6c34\u6676\u4f53\u306e\u6b63\u5e38\u69cb\u9020\u3068\u4ee3\u8b1d. In: \u5927\u9e7f\u54f2\u90ce, \u5712\u7530\u5eb7\u5e73, \u8fd1\u85e4\u5cf0\u751f, \u7a32\u8c37\u5927, eds. \u773c\u79d1\u5b66 \u7b2c3\u7248. \u6771\u4eac: \u6587\u5149\u5802, 2020: 219-222.\n<\/li>\n
      2. \u4f50\u3005\u6728\u6d0b. I\u5dfb I. \u69cb\u9020\u3068\u305d\u306e\u5f62\u614b G. \u6c34\u6676\u4f53 2. \u6c34\u6676\u4f53\u306e\u75c5\u614b 3)\u767d\u5185\u969c \u2461\u767d\u5185\u969c\u5404\u8ad6 In: \u5927\u9e7f\u54f2\u90ce, \u5712\u7530\u5eb7\u5e73, \u8fd1\u85e4\u5cf0\u751f, \u7a32\u8c37\u5927, eds. \u773c\u79d1\u5b66 \u7b2c3\u7248. \u6771\u4eac: \u6587\u5149\u5802, 2020: 236-244.\n<\/li>\n
      3. \u4f50\u3005\u6728\u6d0b. 24 \u773c\u79d1\u75be\u60a3 \u767d\u5185\u969c. In: \u798f\u4e95\u6b21\u77e2, \u9ad8\u6728\u8aa0, \u5c0f\u5ba4\u4e00\u6210, eds. \u4eca\u65e5\u306e\u6cbb\u7642\u6307\u91dd 2020\u5e74\u7248. \u6771\u4eac: \u533b\u5b66\u66f8\u9662, 2020: v. 62, 2192.\n<\/li>\n
      4. \u4f50\u3005\u6728\u6d0b. II. \u5c02\u9580\u533b\u306e\u7ba1\u7406\u30fb\u6cbb\u7642\u304c\u5fc5\u8981\u306a\u75be\u60a3\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3 \u611f\u899a\u5668\u75be\u60a3 26. \u767d\u5185\u969c. In: \u6cc9\u5b5d\u82f1, ed. \u30ac\u30a4\u30c9\u30e9\u30a4\u30f3 \u5916\u6765\u8a3a\u76422020. \u6771\u4eac: \u65e5\u7d4cBP, 2020: v. 20, 549-552.\n<\/li>\n
      5. \u4f50\u3005\u6728\u6d0b. 3. \u8a3a\u7642\u7de8 \u8996\u529b\u826f\u597d\u4f8b\u3067\u306e\u767d\u5185\u969c\u624b\u8853\u3000\u77ef\u6b63\u8996\u529b\u304c\u826f\u597d\u306a\u76ae\u8cea\u767d\u5185\u969c\u306e\u75c7\u4f8b. In: \u5927\u9e7f\u54f2\u90ce, \u5927\u6a4b\u88d5\u4e00, eds. \u773c\u79d1\u8a3a\u7642\u30d3\u30b8\u30e5\u30a2\u30eb\u30e9\u30fc\u30cb\u30f3\u30b0. \u6771\u4eac: \u4e2d\u5c71\u66f8\u5e97, 2020: v. 4, 176-180.\n<\/li>\n
      6. \u4f50\u3005\u6728\u6d0b. 7. \u6c34\u6676\u4f53 1) \u6c34\u6676\u4f53\u7570\u5e38 (1) \u767d\u5185\u969c\u306e\u57fa\u672c\u75c5\u578b(\u6838, \u76ae\u8cea, \u5f8c\u56ca\u4e0b). In: \u5927\u9e7f\u54f2\u90ce, \u5916\u5712\u5343\u6075, eds. \u773c\u75be\u60a3\u30a2\u30c8\u30e9\u30b9\u30b7\u30ea\u30fc\u30ba \u7b2c1\u5dfb \u524d\u773c\u90e8\u30a2\u30c8\u30e9\u30b9. \u6771\u4eac: \u7dcf\u5408\u533b\u5b66\u793e, 2020: 372-374.\n<\/li>\n
      7. \u4f50\u3005\u6728\u6d0b. 7. \u6c34\u6676\u4f53 1) \u6c34\u6676\u4f53\u7570\u5e38 (2) \u767d\u5185\u969c\u306e\u526f\u75c5\u578b. In: \u5927\u9e7f\u54f2\u90ce, \u5916\u5712\u5343\u6075, eds. \u773c\u75be\u60a3\u30a2\u30c8\u30e9\u30b9\u30b7\u30ea\u30fc\u30ba \u7b2c1\u5dfb \u524d\u773c\u90e8\u30a2\u30c8\u30e9\u30b9. \u6771\u4eac: \u7dcf\u5408\u533b\u5b66\u793e, 2020: 375-377.\n<\/li>\n<\/ol>\n

        <\/p>\n\n\n

        <\/p>\n","protected":false},"excerpt":{"rendered":"

        2020\u5e74\u5ea6 \u82f1\u6587\u539f\u8457 Hidetoshi Ishida, Teppei Shibata, Yuka Nakamura, Yasuhito Ishigaki, Dhirendra P. Singh, Hiroshi Sa<\/p>\n